Page last updated: 2024-11-02

papaverine and Tachycardia, Ventricular

papaverine has been researched along with Tachycardia, Ventricular in 7 studies

Papaverine: An alkaloid found in opium but not closely related to the other opium alkaloids in its structure or pharmacological actions. It is a direct-acting smooth muscle relaxant used in the treatment of impotence and as a vasodilator, especially for cerebral vasodilation. The mechanism of its pharmacological actions is not clear, but it apparently can inhibit phosphodiesterases and it may have direct actions on calcium channels.
papaverine : A benzylisoquinoline alkaloid that is isoquinoline substituted by methoxy groups at positions 6 and 7 and a 3,4-dimethoxybenzyl group at position 1. It has been isolated from Papaver somniferum.

Tachycardia, Ventricular: An abnormally rapid ventricular rhythm usually in excess of 150 beats per minute. It is generated within the ventricle below the BUNDLE OF HIS, either as autonomic impulse formation or reentrant impulse conduction. Depending on the etiology, onset of ventricular tachycardia can be paroxysmal (sudden) or nonparoxysmal, its wide QRS complexes can be uniform or polymorphic, and the ventricular beating may be independent of the atrial beating (AV dissociation).

Research Excerpts

ExcerptRelevanceReference
"We investigated the effect of the papaverine dose increment method to confirm maximal hyperemia for fractional flow reserve (FFR) measurements."7.96Confirmation of maximal hyperemia by the incremental dose of intracoronary papaverine. ( Iwasaki, K; Nakayama, M; Tanaka, N; Yamashita, J, 2020)
" Intracoronary papaverine (PAP) is the most potent vasodilator used for the achievement of maximal hyperemia."4.02Clinical Efficacy of Intracoronary Papaverine After Nicorandil Administration for Safe and Optimal Fractional Flow Reserve Measurement. ( Anai, R; Araki, M; Inoue, K; Kataoka, M; Miura, T; Naka, Y; Okabe, H; Setoyama, K; Sonoda, S, 2021)
"We investigated the effect of the papaverine dose increment method to confirm maximal hyperemia for fractional flow reserve (FFR) measurements."3.96Confirmation of maximal hyperemia by the incremental dose of intracoronary papaverine. ( Iwasaki, K; Nakayama, M; Tanaka, N; Yamashita, J, 2020)
"Three cases with polymorphous ventricular tachycardia following a standard dose of intracoronary papaverine during 102 measurements of coronary flow reserve are reported."1.29Polymorphous ventricular tachycardia after intracoronary papaverine: a report of 3 cases. ( Cai, X; Shen, W; Zhang, X; Zheng, A, 1993)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19901 (14.29)18.7374
1990's1 (14.29)18.2507
2000's0 (0.00)29.6817
2010's3 (42.86)24.3611
2020's2 (28.57)2.80

Authors

AuthorsStudies
Inoue, K1
Sonoda, S1
Naka, Y1
Okabe, H1
Setoyama, K1
Miura, T1
Anai, R1
Araki, M1
Kataoka, M1
Nakayama, M3
Tanaka, N3
Yamashita, J2
Iwasaki, K1
Nauchi, M1
Sakai, T1
Yamawaki, M1
Ito, Y1
Sakoda, K1
Hokama, Y1
Hoshino, K2
Kimura, Y1
Ogawa, M1
Kobori, Y1
Uchiyama, T1
Aizawa, Y2
Yamashina, A2
Saito, A1
Kitazawa, H1
Takahashi, M1
Sato, M1
Fuse, K1
Okabe, M1
HARRIS, AS1
ESTANDIA, A1
BISTENI, A1
SMITH, HT1
Zhang, X1
Shen, W1
Cai, X1
Zheng, A1

Other Studies

7 other studies available for papaverine and Tachycardia, Ventricular

ArticleYear
Clinical Efficacy of Intracoronary Papaverine After Nicorandil Administration for Safe and Optimal Fractional Flow Reserve Measurement.
    International heart journal, 2021, Sep-30, Volume: 62, Issue:5

    Topics: Aged; Aged, 80 and over; Arrhythmias, Cardiac; Case-Control Studies; Coronary Angiography; Coronary

2021
Confirmation of maximal hyperemia by the incremental dose of intracoronary papaverine.
    Cardiovascular intervention and therapeutics, 2020, Volume: 35, Issue:4

    Topics: Aged; Coronary Angiography; Coronary Stenosis; Coronary Vessels; Dose-Response Relationship, Drug; E

2020
Sinus Standstill in a Patient after Intracoronary Papaverine Administration for a Coronary Fractional Flow Reserve.
    International heart journal, 2018, May-30, Volume: 59, Issue:3

    Topics: Aged; Coronary Vessels; Electrocardiography; Female; Fractional Flow Reserve, Myocardial; Humans; Pa

2018
Papaverine-induced polymorphic ventricular tachycardia during coronary flow reserve study of patients with moderate coronary artery disease.
    Circulation journal : official journal of the Japanese Circulation Society, 2015, Volume: 79, Issue:3

    Topics: Aged; Coronary Artery Disease; Electrocardiography; Female; Humans; Incidence; Male; Middle Aged; Pa

2015
Papaverine-induced polymorphic ventricular tachycardia in relation to QTU and giant T-U waves in four cases.
    Internal medicine (Tokyo, Japan), 2012, Volume: 51, Issue:4

    Topics: Aged; Coronary Angiography; Coronary Stenosis; Coronary Vessels; Electrocardiography; Female; Fracti

2012
Effects of papaverine upon ectopic ventricular tachycardia produced by myocardial infarction.
    Circulation, 1953, Volume: 8, Issue:6

    Topics: Myocardial Infarction; Papaverine; Tachycardia; Tachycardia, Ventricular; Ventricular Premature Comp

1953
Polymorphous ventricular tachycardia after intracoronary papaverine: a report of 3 cases.
    Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih, 1993, Volume: 8, Issue:4

    Topics: Adult; Aged; Coronary Angiography; Female; Humans; Injections, Intra-Arterial; Male; Middle Aged; Pa

1993